Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.28    0.01 (3.70%)
Bid:
0.27
Ask:
0.29
Spread: 0.02 (7.407%)
Market Cap: £16.23m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Trading update for year ending 30 June 2017

7 Jun 2017 07:00

RNS Number : 3786H
CAP-XX Limited
07 June 2017
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

7 June 2017

 

 

CAP-XX Limited

("CAP-XX" or the "Company")

 

Trading update for year ending 30 June 2017

 

 

CAP-XX Limited, a world leader in the design and manufacture of supercapacitors, which considerably extend the performance of batteries, today announces a trading update for the year ending 30 June 2017.

 

CAP-XX has continued to make excellent progress in advancing negotiations on new licencing agreements and high value customer contracts for its range of supercapacitors. Its existing licencees, AVX and Murata, continue to perform strongly. AVX has paid ahead of schedule GBP 750,000 of licence fees due to CAP-XX under existing agreements, whilst the royalty payments from Murata continue to increase, with the last quarterly royalty payment being the highest ever, up by over 50% compared to the same period in the prior year. The Company continues to develop and expand its licencing and new business opportunities.

 

The Board noted in the interim statement on 20 March 2017 that they expected to finalise additional licence and sales opportunities by the 30th June 2017. Whilst the Board remains very confident that new licence deals and sales opportunities will be realised in the next few months, it now believes that certain of these licence opportunities may not be completed prior to the end of the current financial year.

 

As a result of these delays, the Board now expects that revenues for the year ending 30 June 2017 will be A$4.11 million that, as a consequence, the EBITDA loss generated by Company for the year ending 30 June 2017 will be A$1.15 million.

The Company has adequate cash resources to meet its foreseeable needs and the Board is increasingly confident of a successful conversion of the growing pipeline of high value enquiries received for licensing and manufactured products.

 

For further information contact:

 

CAP-XX Limited

Anthony Kongats (Chief Executive Officer) +61 (0) 2 9428 0139

 

 

Allenby Capital Limited (Nominated Adviser and Broker)

David Hart/Alex Brearley (Corporate Finance) +44 (0) 20 3328 5656

 

Kreab

Robert Speed (Financial PR) +44 (0) 20 7074 1800

 

More information is available at www.cap-xx.com

 

 

Notes to Editors:

 

CAP-XX (LSE:CPX) is a world leader in the design and manufacture of thin flat supercapacitors and energy management systems used in a range of applications including portable and small-scale electronic devices; automotive; and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visit www.cap-xx.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKMGGVKNDGNZG
Date   Source Headline
2nd Feb 20267:00 amRNSInterim Results
23rd Jan 20267:00 amRNSNotice of Interim Results & Investor Presentation
19th Dec 202510:13 amRNSReceipt of R&D tax credit
19th Dec 202510:13 amRNSReceipt of R&D tax credit
10th Dec 20252:16 pmRNSHolding(s) in Company
28th Nov 20255:00 pmRNSTotal Voting Rights
28th Nov 202510:13 amRNSResult of AGM
14th Nov 20257:00 amRNSIssue of Shares and Director/PDMR Shareholding
10th Nov 20257:00 amRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSFinal results and notice of AGM
30th Oct 20251:02 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSHolding(s) in Company
16th Sep 20257:00 amRNSImplementation of Warehouse Management System
10th Sep 202511:48 amRNSHolding(s) in Company
7th Aug 20257:00 amRNSHolding(s) in Company
5th Aug 20257:00 amRNS-RDesign Win with Global Semiconductor Manufacturer
31st Jul 20255:00 pmRNSTotal Voting Rights
25th Jul 20257:00 amRNSHolding(s) in Company
18th Jul 20257:00 amRNSUpdate re. collaboration with SCHURTER
2nd Jul 20257:00 amRNSHolding(s) in Company
1st Jul 20257:29 amRNSIssue of Shares and Director/PDMR Shareholdings
30th Jun 20257:00 amRNSGlobal Distribution Agreement with RS Group plc
9th Jun 20257:00 amRNSBusiness Update and Appointment of Interim CFO
30th May 202510:32 amRNS-RUpdated website
13th May 202511:31 amRNS-RDesign Win with Multinational Conglomerate
30th Apr 20251:57 pmRNSChange of Auditor
26th Mar 20257:00 amRNSGrant of share options
19th Mar 20257:00 amRNSChange of Board Structure and Grant of Options
18th Mar 20259:35 amRNSGlobal Distribution Agreement with Premier Farnell
12th Mar 20252:43 pmRNSTechnology Cooperation Agreement with SCHURTER
7th Mar 20257:00 amRNSMaster Distribution Agreement with Waldom
17th Feb 20257:00 amRNSHalf-year Results
11th Feb 20257:00 amRNSNotice of Interim Results & Investor Presentation
31st Jan 20255:00 pmRNSTotal Voting Rights
21st Jan 20254:27 pmRNSIssue of Shares and Director/PDMR Shareholding
20th Jan 20257:00 amRNSUpdate re. R&D Tax Credit
20th Jan 20257:00 amRNSUpdate re. R&D Tax Credit
17th Jan 20257:00 amRNS-RDistribution agreement with JM Elektronik
15th Jan 20257:00 amRNSFirst shipment to SCHURTER AG
13th Jan 202511:29 amRNSResult of AGM
7th Jan 20257:00 amRNSManagement and board changes
31st Dec 20241:00 pmRNSTotal Voting Rights
9th Dec 202410:19 amRNSNotice of AGM
5th Dec 20248:18 amRNSResult of General Meeting
29th Nov 20245:00 pmRNSTotal Voting Rights
29th Nov 20249:57 amRNSDirectors' Subscription
29th Nov 20247:00 amRNSAudited results for the year ended 30 June 2024
5th Nov 20247:00 amRNSResult of Retail Offer, Notice of GM and TVR
1st Nov 20247:00 amRNSResult of Placing
31st Oct 20244:40 pmRNSRetailBook Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.